All changes for the tissue nervous system (640)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA35
calmodulin 3 (phosphorylase kinase, delta)
Molecular
brain
Human
CALM3
10.0% Decrease Gene Expression Level
DAA40
cholecystokinin B receptor
Molecular
brain
Human
CCKBR
11.0% Decrease Gene Expression Level
DAA44
carbamoyl-phosphate synthetase 1, mitochondrial
Molecular
brain
Human
CPS1
20.0% Increase Gene Expression Level
DAA31
carbonic anhydrase XI
Molecular
brain
Human
CA11
6.0% Decrease Gene Expression Level
DAA16
ATPase, Ca++ transporting, plasma membrane 2
Molecular
brain
Human
ATP2B2
23.0% Decrease Gene Expression Level
DAA5
actin-like 6A
Molecular
brain
Human
ACTL6A
21.0% Increase Gene Expression Level
DAA21
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2
Molecular
brain
Human
ATP6V1G2
7.0% Decrease Gene Expression Level
DAA45
Cdc2-related kinase, arginine/serine-rich
Molecular
brain
Human
CDK12
17.0% Increase Gene Expression Level
DAA19
ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1
Molecular
brain
Human
ATP6V0D1
8.0% Decrease Gene Expression Level
DAA235
transgelin 3
Molecular
brain
Human
TAGLN3
5.0% Decrease Gene Expression Level
DAA20
ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A
Molecular
brain
Human
ATP6V1A
7.0% Decrease Gene Expression Level
DAA767
Cognitive executive functions decline
Psychological
brain
Human
—
—
DAA618
Acute rheumatic fever and chronic rheumatic heart diseases
Pathological
heart, skin, brain
Human
—
SeriesMorbidity
DAA2041
Altered brain mitochondrial metabolism
Physiological
brain
Human
—
—
DAA27
chromosome 1 open reading frame 95
Molecular
brain
Human
C1orf95
5.0% Decrease Gene Expression Level
DAA39
cholecystokinin
Molecular
brain
Human
CCK
6.0% Decrease Gene Expression Level
DAA761
Activation threshold for long-term potentiation is increased
Psychological
brain
Human
—
—
DAA95
cell division cycle 2-like 2 (PITSLRE proteins)
Molecular
brain
Human
CDC2L2
27.0% Increase Gene Expression Level
DAA738
Cerebral spinal fluid amount increases
Physiological
brain
Human
—
—
DAA741
Cerebral blood flow and glucose utilization are reduced
Physiological
brain
Human
—
—
DAA17
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle
Molecular
brain
Human
ATP5A1
17.0% Decrease Gene Expression Level
DAA748
Altered sleep parameters and patterns
Psychological
brain
Human
—
—
DAA18
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
Molecular
brain
Human
ATP5B
9.0% Decrease Gene Expression Level
DAA29
chromosome 6 open reading frame 106
Molecular
brain
Human
C6orf106
12.0% Decrease Gene Expression Level
DAA753
Cognitive deficits
Psychological
brain
Human
—
—
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA35 | calmodulin 3 (phosphorylase kinase, delta) | Molecular | brain | Human | CALM3 | 10.0% Decrease Gene Expression Level | |
DAA40 | cholecystokinin B receptor | Molecular | brain | Human | CCKBR | 11.0% Decrease Gene Expression Level | |
DAA44 | carbamoyl-phosphate synthetase 1, mitochondrial | Molecular | brain | Human | CPS1 | 20.0% Increase Gene Expression Level | |
DAA31 | carbonic anhydrase XI | Molecular | brain | Human | CA11 | 6.0% Decrease Gene Expression Level | |
DAA16 | ATPase, Ca++ transporting, plasma membrane 2 | Molecular | brain | Human | ATP2B2 | 23.0% Decrease Gene Expression Level | |
DAA5 | actin-like 6A | Molecular | brain | Human | ACTL6A | 21.0% Increase Gene Expression Level | |
DAA21 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 | Molecular | brain | Human | ATP6V1G2 | 7.0% Decrease Gene Expression Level | |
DAA45 | Cdc2-related kinase, arginine/serine-rich | Molecular | brain | Human | CDK12 | 17.0% Increase Gene Expression Level | |
DAA19 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 | Molecular | brain | Human | ATP6V0D1 | 8.0% Decrease Gene Expression Level | |
DAA235 | transgelin 3 | Molecular | brain | Human | TAGLN3 | 5.0% Decrease Gene Expression Level | |
DAA20 | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A | Molecular | brain | Human | ATP6V1A | 7.0% Decrease Gene Expression Level | |
DAA767 | Cognitive executive functions decline | Psychological | brain | Human | — | — | |
DAA618 | Acute rheumatic fever and chronic rheumatic heart diseases | Pathological | heart, skin, brain | Human | — | SeriesMorbidity | |
DAA2041 | Altered brain mitochondrial metabolism | Physiological | brain | Human | — | — | |
DAA27 | chromosome 1 open reading frame 95 | Molecular | brain | Human | C1orf95 | 5.0% Decrease Gene Expression Level | |
DAA39 | cholecystokinin | Molecular | brain | Human | CCK | 6.0% Decrease Gene Expression Level | |
DAA761 | Activation threshold for long-term potentiation is increased | Psychological | brain | Human | — | — | |
DAA95 | cell division cycle 2-like 2 (PITSLRE proteins) | Molecular | brain | Human | CDC2L2 | 27.0% Increase Gene Expression Level | |
DAA738 | Cerebral spinal fluid amount increases | Physiological | brain | Human | — | — | |
DAA741 | Cerebral blood flow and glucose utilization are reduced | Physiological | brain | Human | — | — | |
DAA17 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle | Molecular | brain | Human | ATP5A1 | 17.0% Decrease Gene Expression Level | |
DAA748 | Altered sleep parameters and patterns | Psychological | brain | Human | — | — | |
DAA18 | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | Molecular | brain | Human | ATP5B | 9.0% Decrease Gene Expression Level | |
DAA29 | chromosome 6 open reading frame 106 | Molecular | brain | Human | C6orf106 | 12.0% Decrease Gene Expression Level | |
DAA753 | Cognitive deficits | Psychological | brain | Human | — | — |